ArticleFrontiers in oncology2025

De-escalating adjuvant therapy after pathologic complete response in oral squamous cell carcinoma: Chemoradiotherapy benefits only high-risk subgroups.

Yanjie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.